David J. Schlanger - 13 Oct 2022 Form 4 Insider Report for Progyny, Inc. (PGNY)

Signature
/s/ Mark Livingston, Attorney-in-Fact
Issuer symbol
PGNY
Transactions as of
13 Oct 2022
Net transactions value
-$86,645
Form type
4
Filing time
17 Oct 2022, 17:02:18 UTC
Previous filing
07 Oct 2022
Next filing
19 Oct 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGNY Common Stock Options Exercise $364 +400 +0.48% $0.9100* 82,948 13 Oct 2022 Direct
transaction PGNY Common Stock Sale $15,784 -400 -0.48% $39.46 82,548 13 Oct 2022 Direct F1, F2
transaction PGNY Common Stock Options Exercise $1,684 +1,850 +2.2% $0.9100* 84,398 14 Oct 2022 Direct
transaction PGNY Common Stock Sale $72,908 -1,850 -2.2% $39.41 82,548 14 Oct 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGNY Option (Right to Buy) Options Exercise $0 -400 -0.03% $0.000000 1,422,478 13 Oct 2022 Common Stock 400 $0.9100 Direct F4
transaction PGNY Option (Right to Buy) Options Exercise $0 -1,850 -0.13% $0.000000 1,420,628 14 Oct 2022 Common Stock 1,850 $0.9100 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.44 to $39.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.40 to $39.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 These options are fully vested and exercisable.